[Therapy of heart rhythm disorders in infancy and childhood].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000404:Ajmaline / Q000008:administration & dosage / Q000627:therapeutic use; D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000628:therapy*; D001919:Bradycardia / Q000188:drug therapy / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D004071:Digitalis Glycosides / Q000008:administration & dosage / Q000627:therapeutic use; D004554:Electric Countershock; D004562:Electrocardiography; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy / Q000628:therapy*; D009921:Metaproterenol / Q000008:administration & dosage / Q000627:therapeutic use; D010138:Pacemaker, Artificial; D013034:Sparteine / Q000008:administration & dosage / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy; D013614:Tachycardia, Paroxysmal / Q000628:therapy
D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D004071:Digitalis Glycosides; D000404:Ajmaline; D013034:Sparteine; D009921:Metaproterenol
Zur Therapie der herzhythmusstörungen im Säuglings- und Kindesalter.